Relationship Between Plasma Aldosterone Concentrations and Non-Alcoholic Fatty Liver Disease Diagnosis in Patients with Hypertension: A Retrospective Cohort Study
Junli Hu,Xintian Cai,Qing Zhu,Mulalibieke Heizhati,Wen Wen,Qin Luo,Jing Hong,Yujie Dang,Wenbo Yang,Nanfang Li
DOI: https://doi.org/10.2147/DMSO.S408722
2023-06-06
Abstract:Junli Hu, 1– 5, &ast Xintian Cai, 1– 6, &ast Qing Zhu, 1– 6 Mulalibieke Heizhati, 1– 5 Wen Wen, 1– 6 Qin Luo, 1– 5 Jing Hong, 1– 5 Yujie Dang, 1– 6 Wenbo Yang, 1– 5 Nanfang Li 1– 5 1 Hypertension Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People's Republic of China; 2 Xinjiang Hypertension Institute, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People's Republic of China; 3 NHC Key Laboratory of Hypertension Clinical Research, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People's Republic of China; 4 Key Laboratory of Xinjiang Uygur Autonomous Region, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People's Republic of China; 5 Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People's Republic of China; 6 Graduate School, Xinjiang Medical University, Urumqi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Nanfang Li, Hypertension Center, People's Hospital of Xinjiang Uygur Autonomous Region, No. 91 Tianchi Road, Urumuqi, Xinjiang, 830001, People's Republic of China, Tel +86 8564818, Email Objective: To investigate the association between plasma aldosterone concentration (PAC) and non-alcoholic fatty liver disease (NAFLD) diagnosis in Chinese hypertensive patients. Methods: We conducted a retrospective study of all patients diagnosed with hypertension between January 1, 2010, and December 31, 2021. We included 3713 hypertensive patients based on the criteria for inclusion and exclusion. PAC measurement was performed using a radioimmunoassay. NAFLD was diagnosed using abdominal ultrasonography. Cox regression analysis was used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for univariable and multivariable models. A generalized additive model was used to identify nonlinear relationships between PAC and NAFLD diagnosis. Results: A total of 3713 participants were included in the analysis. Over a median follow-up of 30 months, 1572 hypertensive individuals developed new-onset NAFLD. When PAC was used as a continuous variable, the risk of NAFLD increased by 1.04 and 1.24-fold for each 1 ng/dL and 5 ng/dL increase in PAC, respectively. When PAC was considered a categorical variable, the HR for tertile 3 was 1.71 (95% CI, 1.47– 1.98, P < 0.001) compared to tertile 1. Overall, there was a J-shaped relationship between PAC and new-onset NAFLD. By fitting a two-piecewise linear regression model and using a recursive algorithm, we identified a PAC inflection point at 13 ng/dL (log-likelihood ratio test, P = 0.005). In adjusted model 3, for PAC ≥ 13 ng/dL, a 5 ng/dL increase in PAC was associated with a 30% increase in the risk of new-onset NAFLD (95% CI, 1.25– 1.35, P < 0.001). Conclusion: The study revealed a non-linear relationship between elevated PAC levels and the incidence of NAFLD in hypertensive patients. Notably, the risk of new-onset NAFLD was significantly increased when PAC levels were ≥ 13 ng/dL. Larger, prospective studies are necessary to confirm these findings. Keywords: plasma aldosterone concentration, non-alcoholic fatty liver disease, hypertension, cohort study Non-alcoholic fatty liver disease (NAFLD) is a prevalent liver disease that affects over 25% of adults globally and is a leading cause of liver diseases. 1–3 Featuring a range of disorders from simple steatosis to the more severe non-alcoholic steatohepatitis (NASH) and fibrosis, NAFLD is a progressive disease that can result in cirrhosis and, eventually, hepatocellular carcinoma, which currently accounts for most liver transplantations. 2,4–8 Hypertension is a highly significant risk factor for cardiovascular disease (CVD). 9 Additionally, NAFLD can worsen the progression of atherosclerosis, boosting the development of CVD events. 10,11 Bi-directional relationships between NAFLD and hypertension have been observed, with evidence suggesting that NAFLD can both be a consequence and a cause of hypertension. 12 Moreover, the coexistence of hypertension and NAFLD is associated with considerably worse cardiovascular outcomes compared to either condition alone. 13 Thus, the identification and management of modifiable risk factors are of utmost importance in lowering the burden of NAFLD among hypertensive patients. 14 Aldosterone, a steroid hormone, is secreted by the adrenal gland to regul -Abstract Truncated-
endocrinology & metabolism